NPPA issued the retail price of the Empagliflozin 5 mg + Metformin Hydrochloride IP 1000 mg (As Extended Release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Alkem Laboratories Limited (Marketer)

Feb 10, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 08, 2025, issued the retail price of the Empagliflozin 5 mg + Metformin Hydrochloride IP 1000 mg (As Extended Release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Alkem Laboratories Limited (Marketer).

The following has been stated:

The Recommended Price (Lower of worked out and claimed price) per tablet for the Empagliflozin 5 mg + Metformin Hydrochloride IP 1000 mg (As Extended Release) will be Rs. 11.83/-.

[Notification No. 19(4413)/2025/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT